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Background: Influenza pandemics are usually caused by the re-assortment of several influenza viruses, results in
the emergence of new influenza virus strains that can infect the entire population. These pandemic strains, as well
as seasonal influenza viruses, are subjected to extensive antigenic change that has, so far, prevented the generation
of a universal vaccine.
Methods: Samples of patients hospitalized due to infection with the pandemic H1N1 influenza virus (A(H1N1)
pdm09) from 2009, when the virus first appeared, until 2013 were analyzed.
Results: While many patients were hospitalized in 2009 due to infection with the pandemic H1N1 influenza virus,
only small percentages of patients were hospitalized later in 2010–2012. Surprisingly, however in 2012–2013, we
noticed that the percentages of patients hospitalized due to the pandemic H1N1 influenza infection increased
significantly. Moreover, the ages of hospitalized patients differed throughout this entire period (2009–2013) and
pregnant women were especially vulnerable to the infection.
Conclusions: High percentages of patients (especially pregnant women) were hospitalized in 2013 due to the A
(H1N1)pdm09 infection, which may have been enabled by an antigenic drift from those which circulated at the
onset of the pandemic.Background
Influenza viruses are responsible for most respiratory in-
fections, affecting all age groups, particularly the elderly
population [1,2]. Annual epidemics of seasonal influenza
are estimated to result in approximately three to five
million cases of severe illness and about 250,000 to
500,000 deaths worldwide (WHO, 2009). The virus
contains a single strand RNA molecule which encodes at
least 12 proteins; of these proteins, M2, an ion channel
protein, neuraminidase (NA) and hemagglutinin (HA)
are expressed on the cell surface of infected cells [3].
In influenza virus-infected cells, the assembly and the
budding of progeny viruses is the final and critical step in
the life cycle of the virus. This step, which significantly
affects disease progression [4], requires the coordinated
localization of the viral HA and NA proteins to lipid rafts
domains on the apical cell membrane [5-7]. Membrane
localization of HA and NA allows the virus to acquire
these glycoproteins by simply budding through the host* Correspondence: michal.mandelboim@sheba.health.gov.il
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unless otherwise stated.cell membrane [8]. To complete viral particle budding, the
viral NA enzyme cleaves sialic acid residues that link the
progeny virus to the infected cells [5].
Because the “foreign” HA and the NA proteins are
found on the virus and on the infected cells, they elicit
innate, humoral and cellular immune responses, directed
against the virus. To avoid this immune attack, both the
HA and the NA proteins undergo extensive antigenic
changes, complicating design of a universal vaccine that
would be effective against all influenza strains. The
WHO vaccine that is administered each year is based on
the antigenic properties of emerging and circulating
strains and contains three influenza virus strains. Never-
theless, every year, millions are infected with influenza.
In addition, influenza pandemics, that occur every few
decades, pose a major global threat. Three influenza
pandemic outbreaks occurred in the 20th century and
one has already been recorded in the current century.
The most devastating, was the 1918 Spanish flu pan-
demic (A/H1N1), which lasted only two years (1918–
1919), but took the lives of approximately 50 millional. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Primer sequences
Fragment HA forward Primers 5'-3' HA reverse Primers 5'-3'
Fragment 1 1 TGT AAA ACG ACG AGT ATA CGA
CTA GCA AAA GCA GGG G
461 CAG GAA ACA GCT ATG ACC TCA TGA
TTG GGC CAY GA
Fragment 2 351 TGT AAA ACG ACG GCC AGT
ACR TGT TAC CCW GGR GAT TTC A
943 CAG GAA ACA GCT ATG ACC GAA
AKG GGA GRC TGG TGT TTA
Fragment 3 379 TGT AAA ACG ACG GCC AGT
ACR TGT TAC CCA GGR GAT TTC
1204 CAG GAA ACA GCT ATG ACC TCT
TTA CCY RCT GTG AA
Fragment 4 736 TGT AAA ACG ACG GCC AGT
AGR ATG RAC TAT TAC TGG AC
1340 CAG GAA ACA GCT ATG ACC TTC
TKC ATT RTA WGT CCA AA
Fragment 5 1124 TGT AAA ACG ACG GCC AGT
TGG ATG GTA YGG TTA YCA YCA
1541 CAG GAA ACA GCT ATG ACC
TCA TAA GTY CCA TTT YTGA
Fragment 6 1204 TGT AAA ACG ACG GCC AGT AAG
ATG AAY ACR CAR TTC ACAG
1778 CAG GAA ACA GCT TCA GTA
GAA ACA ACA AGG GTG TTT
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occurred in 1957 (Asian flu, H2N2) and in 1968 (Hong
Kong flu, H3N2), resulted in approximately 70,000 and
34,000 deaths, respectively, in the US alone [1]. The
most recent influenza (A(H1N1)pdm09) pandemic
emerged in 2009. Although the mortality rate was rela-
tively low, many people around the world were infected
by the virus [9]. The emergence of new pandemic in
recent years provides us with a unique opportunity to
study the virus spread and evolution through out the
years from the time it first appeared until today.
Here, we analyzed data obtained from patients hospi-
talized in the period between May 2009 and May 2013
due to A(H1N1)pdm09 infection. We observed that in
2013 a significant number of patients (including increas-
ing percentages of pregnant women) were hospitalized
due the A(H1N1)pdm09 infection and we suggest that
the virus re-appeared because of antigenic changes it
acquired over the last 4 years.Figure 1 Distribution of H1N1 pandemic virus infection in hospitalize
due to influenza-like syndrome and infected with the pandemic 2009 influenza viruMethods
Ethics
This is a retrospective study performed on anonymous
patient samples that were analyzed for the presence of
various viruses, as part of the routine tests performed in
the Sheba Medical Center. No extra samples were ob-
tained for this research. Therefore, informed consent was
not required. The institutional review board (IRB) of the
Sheba Medical Center approved this research (Helsinki
Number 0402-13-SMC).
Patients and samples
Respiratory clinical samples (nasopharyngeal swabs or
aspirates) were collected from 29,956 patients hospital-
ized at Chaim Sheba Medical Center, Israel, due to
respiratory illnesses, during the winter seasons between
May 2009 and May 2013. 4,674 patients were positive
for A(H1N1)pdm09 virus infection. All patients were
from the same geographical area.d patients. The percentage of patients hospitalized (on a weekly basis, X axis)
s.
ab
Figure 2 Infection peaks and annual infection percentages. The
figure shows the percentages of patients infected with the pandemic
2009 influenza virus between 2009 and 2013. The percentages of
patients hospitalized due to influenza-like syndrome are presented
either at the peak of the infection in each year (a) or as an annual
average of the infection (b). *P < 0 · 05 using the chi-square test.
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Viral genomic RNA was extracted from patient samples
by using the NucliSENS easyMAG (BioMerieux, France).
A(H1N1)pdm09 infection was detected by using a panel
of real-time reverse transcription-PCR (rRT-PCR), as
previously described [10,11].
Phylogenetic analysis
For the phylogenetic analysis, influenza hemagglutinin
protein-specific primers were used by WHO Swine genome
set [12] (Table 1). The Sequencher® 5.0 program (Gencodes
Corporation, Ann Arbor, MI) was used to compare the
nucleotide sequences. Phylogenetic trees were prepared by
nearest neighbor joining analysis using Clustal X with 1000bootstraps and trees were visualized using TreeView or NJ
plot software. The sequences were submitted to the NCBI.
Statistical analysis
The positivity percent was calculated by dividing the
number of positive H1N1pdm samples by the total num-
ber of tests performed in the laboratory. A Binomial 95%
confidence interval was calculated for this rate. The
chi-square test was applied to evaluate the differences in
positivity percent between the compared years and be-
tween the different age groups within the same year. A
p value <0.05 was considered to be statistically significant.
All analyses were performed using SPSS (version
21.0.0. SPSS Inc., Chicago, IL, USA), SAS (SAS 9.1, SAS
Institute Inc, Cary, NC, USA) and Excel softwares.
Results
Rebound of pandemic H1N1 influenza
We demonstrate in this paper that the pandemic
H1N1 influenza virus reappeared in Israel in 2012–
2013. We noticed that the percentages of patients
hospitalized due to the pandemic H1N1 influenza
infection increased significantly in this year. Interes-
tingly, we also observed that pregnant women were
especially vulnerable to the infection. We have started
this research by analyzing the percentages of patients
infected with the A(H1N1)pdm09 virus from the time
it first appeared in the country until 2013. The new
influenza A(H1N1)pdm09 virus was observed in Israel
throughout the entire year of 2009 following its initial
identification in May 2009. A(H1N1)pdm09-infected
patients were hospitalized from May 2009 until the
virus ceased to be prevalent, at the end of the first
quarter of 2010 (Figure 1). From the end of 2010 until
the beginning of 2011, relatively fewer patients were
hospitalized due to the A(H1N1)pdm09 infection.
Only sporadic cases of A(H1N1)pdm09 infection were
reported in the winter season of 2011–12. However,
surprisingly, at the beginning of 2013, the percentages of
patients hospitalized due to A(H1N1)pdm09 infection
increased dramatically (Figure 1).
Figure 2 summarizes the infection peaks and the
annual percentages of patients infected with A(H1N1)
pdm09 virus. As can be seen, in 2009–10, when the
virus first appeared, approximately 60% of the patients
admitted with respiratory disease at week 29 of the year
were infected with the virus strain. In the following
years, infection rates dropped significantly and in 2011–
12 (week 16), at the peak of infection for that year, only
5% of the patients were infected with A(H1N1)pdm09
(Figure 2a) and less than 1% of patients were hospital-
ized due to A(H1N1)pdm09 infection throughout the
entire year (Figure 2b). In week 6 of 2012–13, a dra-
matic increase in the percentages of hospitalized
Figure 3 Age distribution of the infected patients. The age percentages of patients hospitalized due to influenza-like syndrome and infected
with the pandemic 2009 influenza virus. Three periods of infection are presented (X axis). *P < 0 · 05 using the chi-square test.
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presenting infection with the A(H1N1)pdm09 virus
(Figure 2a). Similarly, the annual percentages of patients
hospitalized due to the A(H1N1)pdm09 infection was
higher as compared to 2011–2012 (Figure 2b).
To investigate the reasons accounting for the return of
the pandemic H1N1 influenza virus in 2013, we analyzed
the ages of the infected patients over three periods:
when the virus first appeared (2009–10), when only a
low percentage of patients were infected with the virus
(2010–12; the age of the patients in each year was not
analyzed separately due to the small number of patients
hospitalized in these years) and at 2013, when a rela-
tively high percentage of patients was hospitalized dueFigure 4 The percentage of positive cases for pregnant women.
The percentages (out of the 21–40 age group) of pregnant women
hospitalized due to influenza-like syndrome and infected with the
pandemic 2009 influenza virus from 2009-today (2013). Three periods
of infection are presented (x axis). *P < 0 · 05 using the chi-square test.to the A(H1N1)pdm09 infection. In 2009–10, most of
the infected patients were 21–60 years of age (Figure 3
and Table 2). In 2010–12, equal infection rates were
observed throughout all age groups, with the exception
of adolescent patients, aged 11–20 (Figure 3 and Table 2).
Similarly, in 2012–13, patients 11–20 years of age were
less affected by the A(H1N1)pdm09 virus when com-
pared to other age groups. However, in 2012–13, most
of the A(H1N1)pdm09-infected patients were 21–40 or
61–100 years of age group.
Pregnant women are particularly sensitive to A(H1N1)
pdm09 infection
We next investigated the percentages of males and
females that were hospitalized due to A(H1N1)pdm09
virus infection. Particular focus was placed upon the 21–
40 age group, as in 2013, this group was particularly af-
fected by the A(H1N1)pdm09 virus. The highest number
of patients (between the ages of 21–40) hospitalized due
to influenza symptoms was observed in 2009–10, when
the A(H1N1)pdm09 first appeared (Table 2), with similar
prevalence among males and females (Table 2). In 2010–
12, fewer patients were hospitalized with influenza-like
illness, which equally affected both males and females
(Table 2). In contrast, in 2013, when a new wave of A
(H1N1)pdm09 virus infection arrived, the number and the
percentages of women hospitalized due to A(H1N1)pdm09
infection were much higher than those of the men (Table 2).
More specifically, the percentages of pregnant women
hospitalized due to the pandemic H1N1 influenza virus
infection gradually increased from 2009 until 2013,
accounting for <60% of the women (ages 21–40) infected
in 2013 (Figure 4). A simple logistic regression analysis
(Table 3) showed that within the group of pregnant
women, no differences in the ages of the infected women
were noticed throughout the year, however, as we demon-
strate here, differences in the increased percentages of
infected women were observed in 2012–13.
Table 2 Male and female patient distribution
Age H1N1pdm 2009–10 (1y) H1N1pdm 2009–12 (1y) H1N1pdm 2009–13 (1y) P value
0-10 Patients n 5112 3001 1367
Positive n (%) 879 (17.2) 80.(2.7) 51 (3.7) <.0001
Male n (%) 2908 (56.9) 1784 (59.4) 780 (57.1) 0.0682
Male Positive n (%) 499 (17.2) 39 (.2) 24 (3.1) <.0001
Female n (%) 2204 (43.1) 1217 (40.6) 587 (42.9) 0.0682
Female positive n (%) 380 (17.2) 41 (3.4) 27 (4.6) <.0001
11-20 Patients n 1621 390 205
Positive n (%) 733 (45.2) 20 (5.1) 10 (4.9) <.0001
Male n (%) 927 (57.2) 197 (50.5) 113 (55.1) 0.0573
Male Positive n (%) 412 (44.4) 11 (5.6) 6 (5.3) <.0001
Female n (%) 694 (42.8) 193 (49.5) 92 (44.9) 0.0573
Female positive n (%) 321 (46.3) 9 (4.7) 4 (4.3) <.0001
21-40 Patients n 3888 990 800
Positive n (%) 1606 (41.3) 74 (7.5) 121 (15.1) <.0001
Male n (%) 1978 (50.9) 481 (48.6) 401 (50.1) 0.4317
Male Positive n (%) 828 (41.8) 31 (6.44) 30 (7.48) <.0001
Female n (%) 1910 (49.1) 509 (51.4) 399 (49.9) 0.4317
Female positive n (%) 778 (40.7) 43 (8.44) 91 (22.8) <.0001
Pregnant positive n (%) 158 (20.3) 17 (39.5) 59 (64.8) <.0001
41-60 Patients n 3033 928 864
Positive n (%) 904 (29.8) 76 (8.2) 80 (9.3) <.0001
Male n (%) 1563 (51.5) 503 (54.2) 507 (58.7) 0.008
Male Positive n (%) 464 (29.7) 43 (8.5) 38 (7.5) <.0001
Female n (%) 1470 (48.5) 425 (45.8) 357 (41.3) 0.008
Female positive n (%) 440 (29.9) 33 (7.8) 42 (11.8) <.0001
61-100 Patients n 4497 1975 1872
Positive n (%) 378 (8.4) 50 (2.5) 105 (5.6) <.0001
Male n (%) 2550 (56.7) 1063 (53.8) 976 (52.1) 0.0015
Male Positive n (%) 189 (7.4) 28 (2.6) 58 (5.9) <.0001
Female n (%) 1942 (43.2) 912 (46.2) 896 (47.9) 0.0015
Female positive n (%) 189 (9.7) 22 (2.4) 47 (5.2) <.0001
We included in this table only patients that we were able to define by gender. In bold are the pregnant women.
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influenza virus strains
The differences in the ages of the hospitalized patients
observed throughout the years and the rebound of the A
(H1N1)pdm09 virus infection observed in 2012–13, led
us to hypothesize that the A(H1N1)pdm09 virus hadTable 3 Logistic regression
Variable Odds ratio p-value
Period 2009–10 (Reference) 1
Period 2010-12 (1.33-4.77) 2.52 0.0045
Period 2010-13 (4.53-11.5) 7.21 <.0001
Age (as continuous) 1.01 (0.99-1.04) 0.3486undergone changes during this short period. Several influ-
enza viruses were isolated from the samples collected dur-
ing these years, to amplify their hemagglutinin gene using
the primers described in Table 1. The obtained sequences
were used to build a phylogenetic tree. Viruses isolated in
2009 and in 2013 diverged differently in the phylogenetic
tree (Figure 5). While the influenza strains obtained in
2009 resemble the strain used for the influenza vaccine of
that year, those who were isolated in 2011–13 resembled
other strains, in particular, group 6 viruses.
Discussion and conclusions
Influenza pandemics that occur every few decades put
the entire population at risk [13], and present a huge
Figure 5 Phylogenetic tree. Phylogenetic tree was generated using the primers listed in Table 1. The HA genes of H1N1 viruses cluster into
eight genetic groups defined by amino acid substitution in HA1. The numbers indicate the different subgroups of the pandemic influenza viruses.
Mutations are indicated.
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occurred in 2009 and was caused by the A(H1N1)
pdm09 virus, is the second documented pandemic in-
volving H1N1 influenza viruses. The first one was the
1918 influenza pandemic which killed tens of millions of
people [9]. The 2009 influenza virus resulted from triple
reassortment of bird, swine and human influenza viruses
further combined with a Eurasian pig flu virus [14].
As shown here and by others [15], at the beginning of
2009, unlike most strains of influenza viruses [16], adults
older than 60 years of age were less affected by the A
(H1N1)pdm09 virus [17], while the most affected group
of patients were within the 21–40 year-old age. In con-
trast, we show here, as far as we know, for the first time,
that when the virus returned in 2013, that in addition to
the 21–40 year-old adults, adults over 60 years of age
were particularly sensitive to infection. The reasons ac-
counting for the age-dependent sensitivity of the different
age groups are unknown. Moreover, more women were
hospitalized in 2013 due to A(H1N1)pdm09 virus infec-
tion, which we attribute to the increased hospitalization of
pregnant women observed in 2013. Already in 2009, when
the virus first appeared, pregnant women and obese indi-
viduals were shown to be more susceptible to infection
[18,19]. In 2009–2010 when the A(H1N1)pdm09virus first
appeared other influenza virus strains were hardly de-
tected [20,21]. In later years infections with the following
H3N2 viruses A/Perth/16/2009-like and A/Victoria/361/
2011-like were detected. Furthermore, the pattern ofrespiratory virus infections (other than influenza) changed
during this time period, especially around 2009 [22-24].
We don’t think however that this is the reason of why
more pregnant women were hospitalized in 2013 due to
the A(H1N1)pdm09 infection. Thus, it is currently unknown
why pregnant women are more sensitive to infection with
the pandemic virus.
The 2009 pandemic influenza began in Mexico [9].
The Mexican government closed most of Mexico City's
public and private facilities in an attempt to contain the
spread of the virus; however, it continued to spread
globally. In June 2009, the World Health Organization
(WHO) and the U.S. CDC stopped counting cases of
people infected with the virus and WHO declared the
outbreak of a pandemic.
As reported here and by others [25,26], the pandemic
declined around the world at the beginning of 2010. In
August 2010, the Director-General of the WHO an-
nounced the end of the H1N1 pandemic [27], further
informing that the pandemic influenza virus had moved
into the post-pandemic period and could be considered
a seasonal influenza virus. Today, experts, including at
the WHO, have agreed that an estimated 284,500 people
were killed by the disease, much higher than the initial
estimates of the death toll. We demonstrated here, how-
ever, that the virus did not disappear, as reported by others
as well [28].
However, we submit that the risk of infection with the
H1N1pdm09 virus should still be taken seriously and
Sherbany et al. BMC Infectious Diseases  (2014) 14:710 Page 7 of 8that its ability to cause severe disease has not abated:
while in 2010–2012 the virus was detected at low per-
centages in hospitalized patients, in 2013, infections with
the pandemic influenza virus increased dramatically and
affected a variety of age groups. We suggest that genetic
alterations, which resulted in reduced viral recognition
by antibodies generated against the 2009 pandemic in-
fluenza virus, underlie the return of the A(H1N1)pdm09
virus in 2013. This is despite observations, we made pre-
viously in which we show that around half of the Israeli
population had antibodies against A(H1N1)pdm09 [29].
Nevertheless, the fact that the virus, in 2013, primarily
infected elderly individuals and people at the ages be-
tween 21–40, support the claim that it transformed from
a pandemic virus to a seasonal influenza virus. Still, the
dramatic increase in the percentages of hospitalized
patients, especially pregnant women, in 2013, suggests
that the threat from the pandemic virus still exists.
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